Contemporary trends in utilization of metastasectomy in the era of targeted and immunotherapies.

ABSTRACT:

Background

Metastasectomy is a useful adjunct in the management of metastatic cancer. Widespread adoption of novel targeted and immunotherapies has improved the survival profiles of multiple malignancies, which has potentially altered the role of metastasectomy. This study aimed to characterize trends in metastasectomy across five primary cancers eligible for these therapies.

Methods

The National Inpatient Sample was used to identify patients who underwent metastasectomy in the United States (2016-2021). Patients with procedure codes for resection of the lung, liver, adrenal gland, brain, or small bowel and concurrent diagnosis codes for secondary malignant neoplasm of that site were included. Subjects were subcategorized by primary malignancy: colorectal cancer, lung cancer

SUBMITTER: Passman JE 

PROVIDER: S-EPMC11694562 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature